Janux Therapeutics, Inc. · NASDAQ:JANX
Paradigm Biocapital Advisors LP reported a 6.00% stake in Janux Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Paradigm Biocapital Advisors LP reported a 6.00% stake in Janux Therapeutics, Inc., 3,515,986 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 6.00%
- Shares
- 3,515,986
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Paradigm BioCapital Advisors LP | 6.00% | 3,515,986 |
| Paradigm BioCapital Advisors GP LLC | 6.00% | 3,515,986 |
| Senai Asefaw, M.D. | 6.00% | 3,515,986 |
| Paradigm BioCapital International Fund Ltd. | 5.20% | 3,030,509 |
Source
Related
- Janux Therapeutics, Inc.
- Paradigm Biocapital Advisors LP
- Janux Therapeutics, Inc. shareholders
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Aug 14, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026